BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20534593)

  • 1. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
    Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
    Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
    Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
    Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
    Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
    Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
    Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
    J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
    Mungul A; Cooper L; Brockhausen I; Ryder K; Mandel U; Clausen H; Rughetti A; Miles DW; Taylor-Papadimitriou J; Burchell JM
    Int J Oncol; 2004 Oct; 25(4):937-43. PubMed ID: 15375543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
    Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
    Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation.
    Dalziel M; Huang RY; Dall'Olio F; Morris JR; Taylor-Papadimitriou J; Lau JT
    Glycobiology; 2001 May; 11(5):407-12. PubMed ID: 11425801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
    Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
    Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
    Martin LT; Marth JD; Varki A; Varki NM
    J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
    Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
    Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
    J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
    Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.
    Dimitroff CJ; Pera P; Dall'Olio F; Matta KL; Chandrasekaran EV; Lau JT; Bernacki RJ
    Biochem Biophys Res Commun; 1999 Mar; 256(3):631-6. PubMed ID: 10080950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
    Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J
    J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.
    Hedlund M; Ng E; Varki A; Varki NM
    Cancer Res; 2008 Jan; 68(2):388-94. PubMed ID: 18199532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
    Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
    Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
    Lee A; Chick JM; Kolarich D; Haynes PA; Robertson GR; Tsoli M; Jankova L; Clarke SJ; Packer NH; Baker MS
    Mol Cell Proteomics; 2011 Sep; 10(9):M900538MCP200. PubMed ID: 20167946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.